[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366434-105":59,"doc-detail-366434-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","challenges-and-proposed-solutions-to-the-adoption-of-cell-free-dna-in-screening-detecting-and-prognosticating-colorectal-cancer-minireviews","Challenges and proposed solutions to the adoption of cell free DNA in screening, detecting and prognosticating colorectal cancer - Minireviews","","Early-stage detection and effective treatment of colorectal cancer (CRC) are crucial for long-term survival. Liquid biopsy has become an important, non-invasive route for screening, prognostication, and monitoring minimal residual disease. Cell free DNA (cfDNA) is an approved liquid biopsy analyte. This minireview reviews current challenges in using cfDNA for CRC screening and prognosis, and discusses its potential—especially for detecting driver mutations in healthy, presymptomatic individuals with normal colonic crypts—along with solutions needed for mainstream clinical adoption.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/challenges-and-proposed-solutions-to-the-adoption-of-cell-free-dna-in-screening-detecting-and-prognosticating-colorectal-cancer-minireviews/366434/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/challenges-and-proposed-solutions-to-the-adoption-of-cell-free-dna-in-screening-detecting-and-prognosticating-colorectal-cancer-minireviews/366434.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early detection of colorectal cancer (CRC) emphasized?","Question",{"text":112,"@type":113},"Early-stage detection is vital because it improves long-term survival. It also enables timely intervention that can reduce CRC-related mortality.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does liquid biopsy play in CRC management?",{"text":117,"@type":113},"Liquid biopsy provides non-invasive molecular detection of tumor-derived markers in bodily fluids. It supports screening, prognostication, and surveillance of minimal residual disease.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the main challenges of using cfDNA for screening and detection?",{"text":121,"@type":113},"Detection is hindered by low signal-to-noise ratio from background non-tumor-derived mutations and by low cfDNA amounts in healthy individuals. These factors reduce sequencing performance and limit assay detection capability, making screening difficult.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366434,1790293893,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","| W | J | G | O | World Journal of\u003Cbr>Gastrointestinal Oncology |\n| --- | --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Gastrointest Oncol 2025 August 15; 17(8): 106663  \nDOI: 10.4251/wjgo.v17.i8.106663 ISSN 1948-5204 (online)  \nMINIREVIEWS  \nChallenges and proposed solutions to the adoption of cell free DNA in screening, detecting and prognosticating colorectal cancer  \nMegan Wern-Ee Chua, Dedrick Kok-Hong Chan  \nSpecialty type: Oncology  \nProvenance and peer review:  \nUnsolicited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade B  \nNovelty: Grade C  \nCreativity or Innovation: Grade C  \nScientific Significance: Grade B  \nP-Reviewer: Bordonaro M  \nReceived: March 4, 2025  \nRevised: April 8, 2025  \nAccepted: July 4, 2025  \nPublished online: August 15, 2025  \nProcessing time: 163 Days and 14.3 Hours  \nMegan Wern-Ee Chua, Dedrick Kok-Hong Chan, Department of Colorectal Surgery, National University Hospital, Singapore 119074, Singapore  \nCorresponding author: Dedrick Kok-Hong Chan, Assistant Professor, Department of Colorectal Surgery, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, [Singapore.](Singapore. surckhd@nus.edu.sg)[ surckhd@nus.edu.sg](Singapore. surckhd@nus.edu.sg)  \nAbstract  \nDetection and treatment of colorectal cancer (CRC) at an early stage is vital for long-term survival. Liquid biopsy has emerged as a promising new avenue for non-invasive screening of CRC as well as prognostication and surveillance of minimal residual disease. Cell free DNA (cfDNA) is a promising liquid biopsy analyte and has been approved for use in clinical practice. Here, we explore the current challenges of utilizing cfDNA in the screening and prognostication of CRC but also for detecting driver mutations in healthy, presymptomatic patients with normal colonic crypts. CfDNA for the detection of cancerous or premalignant colonic lesions has already been extensively explored, however few have considered utilizing cfDNA in the detection of driver mutations in healthy patients. Theoretically, this would allow us to detect patients who are at a higher risk of tumorigenesis decades in advance of established malignancy and stratify them into higher risk groups for early-intervention screening programs. We also explore the solutions necessary to overcome the challenges that prevent liquid biopsy from entering mainstream clinical use. The potential for liquid biopsy is immense if these challenges are successfully circumvented, and can dramatically reduce CRC rates as well as improve survival in patients.  \nKey Words: Cell free DNA; Circulating tumour deoxyribonucleic acid; Colorectal cancer; Liquid biopsy; Screening; Detection; Prognostication  \n©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.  \n WJGO  [https://www.wjgnet.com](https://www.wjgnet.com) 1 August 15, 2025  Volume 17  Issue 8   \nChua MWE et al. CfDNA in CRC  \nCore Tip: Cell free DNA (cfDNA) carries information about colorectal cancer-specific genetic and epigenetic alterations which can aid in screening, detection and prognostication. Detection of genetic alterations is made difficult by low signal-tonoise ratio owing to an abundance of background non-tumorigenic mutations. Low amounts of cfDNA in healthy individuals negatively affects the sequencing performance and limit of detection of assays making screening non-feasible. One solution is to harvest cfDNA from peritoneal fluid or stool as this is more representative of the primary tumour compared to plasmaderived cfDNA. Alternatively, increasing the sensitivity of sequencing technologies would allow for the detection of low frequency mutations.  \nCitation: Chua MWE, Chan DKH. Challenges and proposed solutions to the adoption of cell free DNA in screening, detecting and prognosticating colorectal cancer. World J Gastrointest","cbCaifetv3mS8Q3z","https://ap.wps.com/l/cbCaifetv3mS8Q3z","pdf",3428953,16,"English","# Introduction\n## Rationale for focusing on cfDNA\n# Core Tip\n## Technical challenges: low signal-to-noise and low cfDNA input\n## Potential solutions: alternative cfDNA sources and higher-sensitivity sequencing\n# Abstract\n## Screening, prognostication, and minimal residual disease\n## Challenges and solutions for adoption","[{\"question\":\"Why is early detection of colorectal cancer (CRC) emphasized?\",\"answer\":\"Early-stage detection is vital because it improves long-term survival. It also enables timely intervention that can reduce CRC-related mortality.\"},{\"question\":\"What role does liquid biopsy play in CRC management?\",\"answer\":\"Liquid biopsy provides non-invasive molecular detection of tumor-derived markers in bodily fluids. It supports screening, prognostication, and surveillance of minimal residual disease.\"},{\"question\":\"What are the main challenges of using cfDNA for screening and detection?\",\"answer\":\"Detection is hindered by low signal-to-noise ratio from background non-tumor-derived mutations and by low cfDNA amounts in healthy individuals. These factors reduce sequencing performance and limit assay detection capability, making screening difficult.\"}]","Challenges and proposed solutions to the adoption of cell free DNA in screening, detecting and prognosticating colorectal cancer - Minireviews | PDF",1790165533,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e9d721bd6d84db04b8df885e31cd094.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f20b40bfdc5a0aeadd30fbec89b1e216.webp",982,1389,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fec16add30bf57d6efdf273bcaa74348.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79a806438598bf6adcd5e8f73716f9aa.webp",980,1386]